Pages that link to "Q43086324"
Jump to navigation
Jump to search
The following pages link to Non-invasive assessment of liver fibrosis: are we ready? (Q43086324):
Displaying 50 items.
- Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage (Q26773289) (← links)
- Cirrhosis and autoimmune liver disease: Current understanding (Q28070154) (← links)
- Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient data (Q28481485) (← links)
- A quantitative metabolomics profiling approach for the noninvasive assessment of liver histology in patients with chronic hepatitis C (Q30375134) (← links)
- Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus (Q30375738) (← links)
- Two classifiers based on serum peptide pattern for prediction of HBV-induced liver cirrhosis using MALDI-TOF MS. (Q30456214) (← links)
- Non-invasive assessment of liver fibrosis in chronic hepatitis C (Q30474738) (← links)
- Non-invasive score system for fibrosis in chronic hepatitis: proposal for a model based on biochemical, FibroScan and ultrasound data (Q30877287) (← links)
- The utility of thrombopoietin in predicting liver fibrosis in chronic hepatitis B. (Q33816016) (← links)
- Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age (Q33872843) (← links)
- A comparison of four fibrosis indexes in chronic HCV: development of new fibrosis-cirrhosis index (FCI) (Q33877980) (← links)
- A pilot study of serum microRNAs panel as potential biomarkers for diagnosis of nonalcoholic fatty liver disease (Q34070770) (← links)
- Alpha-fetoprotein level as a biomarker of liver fibrosis status: a cross-sectional study of 619 consecutive patients with chronic hepatitis B. (Q34071329) (← links)
- Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B. (Q34892910) (← links)
- Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients. (Q34926896) (← links)
- Urinary metabolite profiling offers potential for differentiation of liver-kidney yin deficiency and dampness-heat internal smoldering syndromes in posthepatitis B cirrhosis patients (Q35034053) (← links)
- Globulin-platelet model predicts minimal fibrosis and cirrhosis in chronic hepatitis B virus infected patients (Q36031303) (← links)
- Circulating microRNAs in nonalcoholic fatty liver disease (Q37046260) (← links)
- Noninvasive assessment of liver damage in chronic hepatitis B. (Q37157860) (← links)
- Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection? (Q37328464) (← links)
- Prediction of fibrosis in hepatitis C patients: assessment using hydroxyproline and oxidative stress biomarkers (Q37468027) (← links)
- Tools for the diagnosis of hepatitis C virus infection and hepatic fibrosis staging. (Q37682493) (← links)
- Ultrasonography (US) and non-invasive diagnostic methods for non-alcoholic fatty liver disease (NAFLD) and early vascular damage. Possible application in a population study on the metabolic syndrome (MS). (Q38052856) (← links)
- Noninvasive evaluation of NAFLD. (Q38141711) (← links)
- Hepatitis B: are non-invasive markers of liver fibrosis reliable? (Q38174256) (← links)
- Circulating CO3-610, a degradation product of collagen III, closely reflects liver collagen and portal pressure in rats with fibrosis. (Q38366999) (← links)
- Prognostic value of the combined use of transient elastography and fibrotest in patients with chronic hepatitis B. (Q38434496) (← links)
- Magnetic resonance imaging and spectroscopy for differential assessment of liver abnormalities induced by Opisthorchis felineus in an animal model (Q38678819) (← links)
- MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice (Q38867829) (← links)
- Noninvasive methods for the assessment of liver fibrosis: A window open on the future? (Q39702780) (← links)
- The risk of hepatocellular carcinoma is decreasing after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B. (Q40157059) (← links)
- Prognostic value of liver fibrosis biomarkers: a meta-analysis. (Q40621139) (← links)
- Checkmate to liver biopsy in chronic hepatitis C? (Q41678369) (← links)
- Assessment of Liver Fibrosis by Transient Elastography Should Be Done After Hemodialysis in End Stage Renal Disease Patients with Liver Disease. (Q41930193) (← links)
- Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration (Q42272013) (← links)
- Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers (Q45149873) (← links)
- Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts the risk of HBV-related liver cancer development. (Q48155717) (← links)
- Liver stiffness diminishes with antiviral response in chronic hepatitis C. (Q50555735) (← links)
- HCV-GenoFibrotest: A combination of viral, liver and genomic (IL28b, ITPA, UGT1A1) biomarkers for predicting treatment response in patients with chronic hepatitis C (Q50557124) (← links)
- Impact of heart failure and changes to volume status on liver stiffness: non-invasive assessment using transient elastography (Q51376998) (← links)
- MR relaxometry of the liver: significant elevation of T1 relaxation time in patients with liver cirrhosis (Q51431525) (← links)
- Fibroscan: a new noninvasive method for evaluation of liver dysfunction in Turner syndrome. (Q51645420) (← links)
- Recent advances in understanding and managing non-alcoholic fatty liver disease. (Q55359842) (← links)
- Serological biomarkers associate ultrasound characteristics of steatohepatitis in mice with liver cancer (Q57483205) (← links)
- Pathologie hépatique Cirrhose et carcinome hépatocellulaire : indications et rôles de la biopsie hépatique (Q57782479) (← links)
- Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: A step toward the truth in the absence of a gold standard (Q58622618) (← links)
- First-line assessment of patients with chronic liver disease with non-invasive techniques and without recourse to liver biopsy (Q58622636) (← links)
- What are the best reference values for a normal serum alanine transaminase activity (ALT)? Impact on the presumed prevalence of drug induced liver injury (DILI) (Q58622652) (← links)
- The Role of Long Non-Coding RNAs (lncRNAs) in the Development and Progression of Fibrosis Associated with Nonalcoholic Fatty Liver Disease (NAFLD) (Q58726261) (← links)
- Diagnostic Accuracy of Aspartate Aminotransferase to Platelet Ratio Index and Fibrosis 4 Scores in Predicting Advanced Liver Fibrosis in Patients with End-stage Renal Disease and Chronic Viral Hepatitis: Experience from Pakistan (Q59349824) (← links)